Last reviewed · How we verify
NCT03425084
Genetic Variation in Organic Cation Transport 1 (OCT1) and Its Significance for Morphine Pharmacokinetics
Phase 1 trial testing Morphine in Organic Cation Transporter 1 in 86 participants. Completed in 7 February 2020.
7 February 2020
Quick facts
| Lead sponsor | University of Southern Denmark |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 86 |
| Start date | 1 June 2018 |
| Primary completion | 7 February 2020 |
| Estimated completion | 7 February 2020 |
| Sites | 2 locations across Denmark |
Drugs / interventions tested
- Morphine
Conditions studied
- Organic Cation Transporter 1 — all drugs for Organic Cation Transporter 1 →
- Morphine — all drugs for Morphine →
Sponsor
University of Southern Denmark
Who can join
Adults 18 to 90, any sex, with Organic Cation Transporter 1 or Morphine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of the trial is to investigate the effect of known genetic variants in organic cation transporter 1 (OCT1) on the effect of morphine after major surgery
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
No significant influence of OCT1 genotypes on the pharmacokinetics of morphine in adult surgical patients.
Kuhlmann I, Hjelmar Petersen R, Overgaard M, Dornonville de la Cour K, et al · · 2022 · cited 5× · PMID 34599645 · DOI 10.1111/bcpt.13667
Verify or expand the search:
- PubMed search for NCT03425084
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Morphine
Trials testing the same drug.
- NCT06315920 — Analgesic Effect of Parecoxib Versus Morphine in SCD Patients Presenting to the Emergency Department · Phase 3 · not yet recruiting
- NCT07491146 — Phase II Clinical Study of the Efficacy and Safety of HSK55718 in the Treatment of Abdominal Postoperative Pain · Phase 2 · not yet recruiting
- NCT07412223 — Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal Surgery · Phase 4 · not yet recruiting
- NCT07246785 — Anrikefon-based Patient-controlled Intravenous Analgesia After Laparoscopic Surgery · Phase 4 · terminated
- NCT07201272 — Transversalis Fascia Plane Block Versus Intrathecal Morphine for Postoperative Analgesia in Total Abdominal Hysterectomy · NA · recruiting
Other University of Southern Denmark trials
Trials by the same sponsor.
- NCT07531290 — PeerScreen Trial - Reducing Screen Media Use in Peer-groups of Young People · NA · not yet recruiting
- NCT07384273 — Evaluating the Effectiveness of an Internet-based Therapy (iCARE) to Treat Symptoms of Postpartum Depression · NA · recruiting
- NCT07426679 — Should Anaesthesiologists Be Taught to Perform Ultrasound-- Assisted Neuraxial Access in Spinal Anaesthesia? · NA · recruiting
- NCT07104292 — Pelvic Floor Muscle Training During Pregnancy · NA · recruiting
- NCT07194759 — Health Literacy Levels of Patients Living With Type 2 Diabetes and Multi-disease and Their Families Using HLQTM · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03425084 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southern Denmark
- Last refreshed: 29 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03425084.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing